- BMS adds Bavarian Nordic's Prostvac to immuno-oncology stable in $975M deal
- Baxter pays $221M for Suppremol ahead of Baxalta spinout
- Micurx kicks off U.S. MRX-1 phase II, looks to top Zyvox for drug-resistant bacteria infections
- Deficit may dim prospects for FDA's 2016 budget request
- Class act: Macrolide bid draws $22M in series A ...
Thomson Reuters analysts have disclosed 10 deals – five biopharma licensing and five M&A deals concluded in 2014 – as candidates for the Breakthrough Alliance Awards, with voting now open and the winner to be announced at this year's Allicense meeting in San Francisco.
Antioxidants seem to be on a Bill Cosby-like downward spiral from wholesomeness to villainy.
The newest accusations can be found in the Feb. 9, 2015, issue of Cancer Cell, where scientists reported that antioxidants drove both the initiation and the progression of tumors, and that blocking antioxidant pathways could destroy tumor cells.
Because they scavenge free radicals, which induce DNA damage as well as other damage in cells, antioxidants were once thought to protect against cancer.
That idea, however, has not held up to scientific scrutiny.
READ MORE »- Researchers find a powerful new dengue neutralizing antibody »
- HIV not the only important virus at CROI conference »
- Export inhibitors ride SINE wave into neurodegeneration »
- Nanotechnology approaches target atherosclerotic plaques »
- Common heart drug interactions traced to vitamin K: study »
- Potent breast cancer candidate targets stem, bulk tumor cells »
- Vaccines can help fight drug resistance »
- Engineered insulin knows when it's needed »
- Brain tissue growth has research, development implications, study says »
- Patient engagement as important as the dataFebruary 20, 2015 | 5:50 PM | Posted by: Mari Serebrov
- Listening to the voice that mattersFebruary 04, 2015 | 3:35 PM | Posted by: Mari Serebrov
- States move forward as SEC lags on crowdfunding rulesJanuary 29, 2015 | 6:55 PM | Posted by: Michael Fitzhugh
- Old dogs and new tricks: The real-world consequences of excluding older adults from drug trialsDecember 10, 2014 | 8:14 PM | Posted by: Marie Powers
- Shoppers, start your engines: BioWorld’s 8th Annual Gift GuideDecember 01, 2014 | 6:12 PM | Posted by: Marie Powers
Partners in Focus
